Vigil Neuroscience
VIGL
VIGL was delisted on the 4th of August, 2025.
54 hedge funds and large institutions have $90.5M invested in Vigil Neuroscience in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 3 closing their positions.
300% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 3
17% more funds holding
Funds holding: 46 → 54 (+8)
7% more capital invested
Capital invested by funds: $84.6M → $90.5M (+$5.99M)
2.16% more ownership
Funds ownership: 69.73% → 71.89% (+2.2%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
33% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.73M |
| 2 |
6CM
683 Capital Management
New York
|
+$3.11M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$297K |
| 4 |
Renaissance Technologies
New York
|
+$187K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$104K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$700K |
| 2 |
DM
Deerfield Management
New York
|
-$603K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$435K |
| 4 |
Morgan Stanley
New York
|
-$270K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$234K |
VIGL Hedge Fund Activity: Q1 2024 in Review
54 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q1 2024, worth a combined $90.5M — up 7.1% from $84.6M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new VIGL positions and 3 closed out — a net gain of 9 holders — while 10 added to existing stakes and 15 trimmed.
The largest buyer was Sphera Funds Management, adding an estimated $3.73M. The largest seller was Anson Funds Management, exiting entirely with an estimated $700K sold.
- 54 institutional investors held Vigil Neuroscience (VIGL) as of Q1 2024, up from 46 in Q4 2023.
- Funds reported $90.5M of Vigil Neuroscience stock for Q1 2024, up 7.1% quarter-over-quarter.
- 12 funds opened new Vigil Neuroscience positions in Q1 2024 and 3 closed out, a net change of +9 holders.
- The largest Vigil Neuroscience buyer in Q1 2024 was Sphera Funds Management, an estimated $3.73M added.
- The largest Vigil Neuroscience seller in Q1 2024 was Anson Funds Management, an estimated $700K sold.
Based on aggregated 13F filings for Q1 2024.